Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sample Size Calculation01:19

Sample Size Calculation

3.2K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
3.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

148
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
148
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

237
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
237
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Sampling Plans01:23

Sampling Plans

169
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
169

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipocalimab for the treatment of moderate-to-severe Sjögren's disease: a plain language summary of the DAHLIAS study.

Expert review of clinical immunology·2026
Same author

Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial.

Lancet (London, England)·2025
Same author

Navigating the Future: Considerations for use of Continuous Glucose Monitoring in Diabetes Trials.

Therapeutic innovation & regulatory science·2025
Same author

Application of Bayesian Borrowing Methods in Clinical Trials for Children with Type II Diabetes Mellitus.

Therapeutic innovation & regulatory science·2025
Same author

Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States.

Lupus·2025
Same author

Bayesian Hierarchical Models for Subgroup Analysis.

Pharmaceutical statistics·2024

Related Experiment Video

Updated: Jun 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.0K

Optimizing Sample Size Determinations for Phase 3 Clinical Trials in Type 2 Diabetes.

Alexander C Cambon1, James Travis1, Liping Sun1

  • 1FDA Center for Drug Evaluation and Research, Office of Translational Science, Office of Biostatistics, Silver Spring, Maryland, USA.

Pharmaceutical Statistics
|October 30, 2024
PubMed
Summary

Accurate variance estimates in adult Type 2 diabetes clinical trials can reduce sample sizes without compromising validity. This optimization aids future endocrinology research and speeds up trial results.

Keywords:
diabetessample size estimationvariance

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

200

Related Experiment Videos

Last Updated: Jun 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.0K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

200

Area of Science:

  • Clinical Trials
  • Endocrinology
  • Diabetes Research

Background:

  • Accurate subject-level variance estimation is crucial for determining appropriate sample sizes in clinical trials.
  • Evaluating past adult Type 2 diabetes studies informs future sample size requirements.
  • The U.S. Food and Drug Administration (FDA) database provides valuable data for such evaluations.

Purpose of the Study:

  • To assess the accuracy of variance estimates in completed adult Type 2 diabetes clinical trials.
  • To inform sample size requirements for future studies based on historical data.
  • To investigate the impact of covariates on residual standard deviation and sample size re-estimation.

Main Methods:

  • Analysis of 26 Phase 3 randomized adult Type 2 diabetes studies submitted to the FDA (2013-2017).
  • Estimation of subject-level variance for change in glycated hemoglobin (HbA1c) from baseline to 6 months.
  • Examination of nine additional studies to assess covariate impact on residual standard deviation and sample size.

Main Results:

  • Reduced sample sizes are feasible for adult Type 2 diabetes drug trials without affecting the validity of efficacy outcomes.
  • Variance estimates from completed studies can guide more efficient sample size calculations.
  • Clinically meaningful covariates can influence residual standard deviation and sample size re-estimation.

Conclusions:

  • Optimized sample sizes can be employed in adult Type 2 diabetes clinical trials.
  • This optimization can shorten recruitment periods and accelerate the delivery of research findings.
  • The findings offer valuable insights for designing future endocrinology and diabetes clinical trials.